Embodiments herein generally relate to automated medication delivery and, more particularly, to wireless medication delivery systems using wearable medication delivery devices.
“Artificial pancreas” systems can be medication delivery systems that typically monitor a user's glucose levels, determine an appropriate level of insulin for the user based on the monitored glucose levels, and subsequently dispense the insulin to the user. Sophisticated control algorithms needed for these systems generally require powerful computing resources and significant power resources. As a result, conventional medication delivery systems do not provide for wireless communications between system components, fully autonomous operation, enhanced user experiences involving ubiquitous electronic devices like cellphones, and improved security features. A need therefore exists for an insulin management system that includes such features.
In the drawings, like reference characters generally refer to the same parts throughout the different views. In the following description, various embodiments of the present invention are described with reference to the following drawings, in which:
Various embodiments of the present invention include systems and methods for delivering a medication to a person using a wearable medical device in accordance with a wireless signal received from an electronic device. In various embodiments, the electronic device is a smart watch, smart necklace, module attached to the medical device, or any other type or sort of electronic device that may be worn or carried on the body of the person and executes an algorithm that computes the times and dosages of delivery of the medication. For example, the electronic device may execute an artificial-pancreas algorithm that computes the times and dosages of delivery of insulin. The electronic device may also be in communication with a sensor, such as a glucose sensor, that collects data on a physical attribute or condition of the person, such as a glucose level. The sensor may be disposed in or on the body of the person and may be part of the medical device or may be a separate device. Alternately, the medical device may be in communication with the sensor in lieu of or in addition to the communication between the sensor and the electronic device. The communication may be direct (if, e.g., the sensor is integrated with or otherwise a part of the medical device) or remote/wireless (if, e.g., the sensor is disposed in a different housing than the medical device). In these embodiments, the sensor and/or medical device contains computing hardware (e.g., a processor, memory, firmware, etc.) that executes some or all of the algorithm that computes the times and dosages of delivery of the medication.
Various embodiments described herein include systems and methods for automatically delivering medication to a user. A sensor coupled to a user can collect information regarding the user. A controller can use the collected information to determine an amount of medication to provide the user. The controller can instruct a drug delivery device to dispense the medication to the user. The drug delivery device can be a wearable insulin pump that is directly coupled to the user. The controller can be part of or implemented in a cellphone. A user can be required to provide a confirmation input to allow a determined amount of insulin to be provided to the user based on detected glucose levels of the user.
The medical device 102 can include a number of components to facilitate automated delivery of a medication to the user. For example, the medical device 102 can include a reservoir for storing the medication, a needle or cannula for delivering the medication into the body of the person, and a pump for transferring the medication from the reservoir, through the needle or cannula, into the body of the user. The medical device 102 can also include a power source such as a battery for supplying power to the pump and/or other components of the medical device 102.
The medical device 102 can store and provide any medication or drug to the user. In various embodiments, the medical device 102 can be an automated wearable insulin delivery device. For example, the medical device 102 can be the OmniPod® (Insulet Corporation, Billerica, Mass.) insulin delivery device as described in U.S. Pat. Nos. 7,303,549, 7,137,964, or 6,740,059, each of which is incorporated herein by reference in its entirety.
The medical device 102 can also contain analog and/or digital circuitry for controlling the delivery of the medication. The circuitry can be implemented as a controller. The circuitry can include discrete, specialized logic and/or components, an application-specific integrated circuit, a microcontroller or processor that executes software instructions, firmware, or any combination thereof. In various embodiments, the control circuitry can be configured to cause the pump to deliver doses of the medication to the person at predetermined intervals. The size and/or timing of the doses may be programmed into the control circuitry using a wired or wireless link by the user or by a third party (such as a health care provider).
Instructions for determining the delivery of the medication to the user (e.g., the size and/or timing of any doses of the medication) can originate locally (e.g., based on determinations made by the medical device 102) or can originate remotely and then provided to the medical device 102. Remote instructions can be provided to the medical device 102 over a wired or wireless link. The medical device 102 can execute any received instructions for the delivery of the medication to the user. In this way, under either scenario, the delivery of the medication to the user can be automated.
In various embodiments, the medical device 102 can communicate via a wireless link 104 with an electronic device 106. The electronic device 106 can be any electronic device such as, for example, an Apple® Watch. The electronic device 106 can be a wearable wireless accessory device. The wireless link 104 can be any type of wireless link provided by any known wireless standard. As an example, the wireless link can provide communications based on Bluetooth®, Wi-Fi, a near-field communication standard, a cellular standard, or any other wireless protocol.
The control circuitry in the medical device 102 may include circuitry implementing a wireless transmitter, receiver, and/or transceiver for communication over the link 104 or 122. Information may be transmitted between the medical device 102 and the electronic device 106 over the link 104 and/or between the medical device 102 and the sensor 108 over the link 122. The shared information may include handshake/pairing information, data, commands, status information, or any other such information.
In various embodiments, the electronic device 106 transmits a command to the medical device 102 that specifies an action for the medical device 102 to take regarding delivery of the medication. In another embodiment, the sensor 108 sends a signal to the medical device 102 via the link 122, and the medical device 102 executes an algorithm to determine an action for the medical device 102 to take regarding delivery of the medication. The action may be delivery of a bolus of the medication, a change in a time, frequency, or schedule of future deliveries of the medication, a change in a size of future deliveries of the medication, or any other such action. The command may further comprise a bolus size, a bolus time, or any other such additional information. The medical device 102 may transmit a confirmation message back to the electronic device 106 upon receipt of the command and/or after completion of the action.
In various embodiments, the electronic device 106 transmits the command as specified by an algorithm executing thereon, such as an artificial-pancreas algorithm. The algorithm may execute in the context of a software application running on the electronic device. The user may download this application from an application store, such as the Apple® iTunes® store, or from any other source. The algorithm may be used to compute appropriate times and doses of delivery of the medication. In some embodiments, the algorithm bases these computations at least in part on information known about the person, such as sex, age, weight, or height, and/or on information gathered about a physical attribute or condition of the person (e.g., from the sensor 108). For example, the algorithm may determine an appropriate delivery of the medication based on glucose level monitoring of the user. The software application may further permit the person to access status information regarding the medical device 102, such as its battery level, number of doses remaining, amount of time in use, or other such status information. The software application may instead or in addition allow the person to issue commands to the medical device 102, such as a command to deliver a bolus.
In various embodiments, as shown in
The sensor 108 can include one or more sensing elements, an electronic transmitter, receiver, and/or transceiver for communicating with the electronic device 106 over a link 110 or with medical device 102 over the link 122. The link 110 can be the same type of wireless link as the links 104 or 122. The sensor 108 can also include a power source for supplying power to the sensing elements and/or transceiver. Communications provided by the sensor 108 may include data gathered from the sensing elements. This data can be transmitted continually, at periodic intervals, and/or during or after a change in sensed data (e.g., if a glucose level or rate of change in the level exceeds a threshold). The software application executing the algorithm may use this collected information to send a command to the medical device 102 to, for example, deliver a bolus to the person, change the amount or timing of future doses, or other commands.
The electronic device 106 can be considered to be a wireless accessory device or an intermediate device. In various embodiments, the electronic device 106 can relay commands for delivery of a medication from a remote source to the medical device 102. In various embodiments, the electronic device 106 can include a controller for determining delivery of the medication (e.g., the electronic device can include a controller for executing an “artificial pancreas” algorithm). The electronic device 106 can also relay sensor data from the sensor 108 to the medical device 102. In general, the electronic device 106 can relay communications between any of the devices depicted in
The sensor 108 can be any type of sensor and is not limited to a CGM. The sensor 108 can include one or more sensors housed in the same physical unit.
The electronic device 106 and/or the medical device 102 may communicate with one more remote devices 112, which may include computers, servers, storage devices, cloud-based services, or other similar devices. The remote device 112 may be owned or operated by, for example, health-care companies or services, pharmacies, doctors, nurses, or other such medically-related entities. The remote device 112 may include a cloud-based data management system. A user may wish, for example, to back up data collected from the sensor 108, back up a record of medication delivery times and doses provided by the medical device 102, or back up other such information. A wireless link 114 may be used to connect the electronic device 106 to the remote devices 112 and/or a wireless link 126 may be used to connect the medical device 102 to the remote devices 112. The wireless links 114 and 126 can be of the same type as the other wireless links described herein.
Alternatively or in addition thereto, the electronic device 106 may communicate with a local device 116. The local device 116 can be a dedicated control or monitoring device (e.g., a diabetes management device an/or a custom handheld electronic computing device), cellular phone, laptop computer, tablet, desktop computer, or other similar electronic computing device. The local device 116 can communicate with the electronic device 106 over a wireless link 118. The wireless link 118 can be of the same type as the other wireless links described herein.
A software application executing on the local device 116 may be used to send commands to the medical device 102 (e.g., via the electronic device 106) and/or receive status information about the medical device 102 (e.g., via the electronic device 106). In other embodiments, the local device 116 instead or in addition communicates directly via a wireless link 124 with the medical device 102. The wireless link 124 can be of the same type as the other wireless links described herein.
Additionally, the sensor 108 may communicate via a wireless link with the local device 116. The local device 116 may communicate with the remote devices 112 via a wireless link 120. The wireless link 120 can be of the same type as the other wireless links described herein.
Each of the wearable automated medication delivery systems 100, 150, and 200 described in relation to
The controller for determining the delivery of insulin to the user, any sensor used for collecting and providing data to the controller, and any device providing monitoring output information and capable of receiving user input information can be distributed in any manner across any number of devices. In various embodiments, a glucose sensor (e.g., the sensor 108) is provided as a separate device from a wearable insulin pump (e.g., the medical device 102). In various embodiments, a glucose sensor (e.g., the sensor 108) is provided as part of a wearable insulin pump (e.g., the medical device 102). In various embodiments, the controller for determining the delivery of insulin to the user (e.g., the controller for executing the “artificial pancreas” algorithm) can be provided within a wearable insulin pump (e.g., the medical device 102). In various embodiments, the controller for determining the delivery of insulin to the user (e.g., the controller for executing the “artificial pancreas” algorithm) can be provided in a separate electronic device (e.g., the electronic device 106, the electronic device 202, the local device 116, or the remote device 112).
In various embodiments, any device or component forming a part of a diabetes management systems provided by the wearable automated medication delivery systems 100, 150, and 200 can communicate wirelessly with any other device or component of the system. Any type of wireless link can be used based on any known wireless standard or protocol. Further, in various embodiments, one or more of the devices or components can communicate with one or more remote severs or computing devices including remote cloud-based server systems to provide further monitoring, backup, storage, and/or processing capabilities. The components shown in the wearable automated medication delivery systems 100, 150, and 200 can communicate directly with one another or can communicate indirectly using a relay or intermediate communication device such as, for example, the electronic device 106 or 202.
In various embodiments, the controller for determining the delivery of insulin to the user (e.g., for executing an “artificial pancreas” algorithm) can be provided as part of an electronic device (e.g., the electronic device 106 or electronic device 202) that is separate from a sensor (e.g., the sensor 108) for monitoring a condition or attribute of the user and separate from a wearable insulin pump (e.g., the medical device 102). Under such a scenario, the sensor 108 can send sensor data (e.g., glucose level data or other user data) to the electronic device 106 or 202. The electronic device 106 or 202 can determine an insulin dose based on the received sensor data. The electronic device 106 or 202 can then communicate the determined dosage to the wearable insulin pump 102. The wearable insulin pump 102 can then automatically provide the dosage to the user without patient input. Monitoring data (e.g., glucose level data and/or dosage data) can be provided to a monitoring device (e.g., the local device 116 or a remote device 112) for storage or review (e.g., presentation of current or past data related to delivery of the insulin to the user).
In various embodiments, the controller for determining the delivery of insulin to the user (e.g., for executing an “artificial pancreas” algorithm) can be provided as part of the wearable insulin pump (e.g., the medical device 102). Under such a scenario, the sensor 108 can send sensor data (e.g., glucose level data or other user data) to the wearable insulin pump 102. The wearable insulin pump 102 can determine an insulin dose based on the received sensor data. The wearable insulin pump 102 can then automatically provide the dosage to the user without patient input. Monitoring data (e.g., glucose level data and/or dosage data) can be provided to a monitoring device (e.g., the local device 116 or a remote device 112) for storage or review (e.g., presentation of current or past data related to delivery of the insulin to the user). Under this scenario, the wearable insulin pump 102 (which can operate as a drug delivery device) can include a communications interface built-in to the wearable insulin pump 102 to provide wireless communication capabilities. Alternatively, an add-on device can be coupled to the wearable insulin pump 102 (e.g., an attachable device) to provide a wireless communication interface and wireless communication capabilities to the wearable insulin pump 102.
In various embodiments, the controller for determining the delivery of insulin to the user (e.g., for executing an “artificial pancreas” algorithm) can be provided as part of the wearable insulin pump (e.g., the medical device 102). Further, the sensor 108 can be provided as part of the wearable insulin pump 102. That is, the sensor 108 can be embedded within the wearable insulin pump 102. Under such a scenario, the sensor 108 can send sensor data (e.g., glucose level data or other user data) to the wearable insulin pump 102. The wearable insulin pump 102 can determine an insulin dose based on the received sensor data. The wearable insulin pump 102 can then automatically provide the dosage to the user without patient input. Monitoring data (e.g., glucose level data and/or dosage data) can be provided to a monitoring device (e.g., the local device 116 or a remote device 112) for storage or review (e.g., presentation of current or past data related to delivery of the insulin to the user).
In various embodiments, the controller for determining the delivery of insulin to the user (e.g., for executing an “artificial pancreas” algorithm) can be provided as part of the local electronic device 116. For example, the local electronic device 116 can be a mobile device or a cellphone. The cellphone 116 can include an app for determining insulin delivery to the user. Under such a scenario, the sensor 108 can send sensor data (e.g., glucose level data or other user data) to the cellphone 116 (e.g., directly or indirectly using the electronic device 106 or 202 as a relay). The cellphone 116 can determine an insulin dose based on the received sensor data. The cellphone 116 can communicate the insulin dosage information to the wearable insulin pump 102. The cellphone 116 can communicate with the wearable insulin pump 102 directly or indirectly—for example, indirectly by way of the electronic device 106 or 202. After receiving the dosage information, the wearable insulin pump 102 can provide the dosage to the user. Monitoring data (e.g., glucose level data and/or dosage data) can be provided to a monitoring device (e.g., the local device 116 or a remote device 112) for storage or review (e.g., presentation of current or past data related to delivery of the insulin to the user). As an alternative to a cellphone, the local device 116 can be a dedicated handheld electronic computing device that does not include all of the capabilities of a cellphone (e.g., does not provide an Internet connection or cellular communications interface).
When dosage information is generated and/or provided from the cellphone 116, user input can be required before the wearable insulin pump 102 is allowed to provide the dosage. For example, a user may be required to confirm a command to provide a dosage before the dosage is provided. The wearable insulin pump 102 or the electronic device 106 can include an output device for alerting the user that user confirmation is requested. The alert can be alarm provided visually, audibly, or by other means (e.g., such as vibrating). The wearable insulin pump 102 or the electronic device 106 can further include a user input device for receiving a confirmation input from the user. For example, the user input can be provided by tapping or pressing a button or by receiving an input using an accelerometer provided on the wearable insulin pump 102 or the electronic device 106. This confirmation requirement can represent a cybersecurity measure for the safety of the user.
In various embodiments, the user can be required to provide a confirmation input within a predetermined amount of time after the alarm is provided. If the confirmation is not received within the predetermined amount of time, then the delivery of the insulin to the user can be blocked. Alternatively, if the confirmation is received within the predetermined amount of time, then delivery can be provided as planned. The alarm or alert can indicate receipt of an instruction relating to delivery of the insulin to the user. The confirmation can protect the user from erroneously scheduled insulin delivery to the user. In various embodiments, when a dedicated handled electronic device is used rather than a cellphone for the local device, such confirmation requirements may not be implemented as the security risk to the user is reduced.
In various embodiments, the electronic device 106 can be provided to include the controller for determining medication dosages and times and/or for providing communications between one or more other components of the systems 100, 150, and 200. In various other embodiments, the electronic device 106 is not necessarily present when the controller for determining medication dosages and times can be housed in another component of the systems 100, 150, and 200 and/or when the other system components can communicate without using the electronic device 106 as an intermediary.
The attached module 302 can include some or all of the features described above with reference to the electronic device 106 of
The electronics module 302 may be removably attached to the medical device 102 so that the electronics module 302 may be used with a plurality of medical devices 102. The electronics module 302 may be sealed and waterproof. The electronics module 302 may have a battery that can be rechargeable using wireless charging.
In various embodiments, the medical device 102 described herein includes a user-input device and/or a user-output device. The user-input device can be a button disposed on the device 102, an acceleration sensor for sensing motion of the medical device 102, or any other such input device. The user-output device may be a speaker for playing sound, a vibration generator (e.g., a motorized gear with an offset center of gravity) for creating vibrations, metal terminals for delivering an electric shock to the body of the person, a visual display and/or one or more lights for providing a visual alarm, or any other such output device.
In various embodiments, when a command is received at the medical device 102 from the electronic device 106, the electronic device 202, or from the local electronic device 116, an action associated with the command (e.g., delivery of a bolus) is not carried out until input is received from the user. The input may include pressing the button on the medical device 102, shaking the medical device 102 (as sensed by the acceleration sensor), tapping the medical device 102 one or more times (as sensed by the acceleration sensor), scanning an RFID or NFC tag, keycard, or fob, or any other such input. If an input is not received within a certain amount of time (e.g., 30 seconds, one minute, two minutes, or any other amount of time), the medical device 102 may not carry out the action. That is, a determined insulin dose may not be delivered. In some embodiments, the output device alerts the person to the arrival of the command at the medical device 102 by, for example, sounding an alarm, vibrating, or providing a visual signal. The output device may similarly alert the user after execution of the action and/or if the action is cancelled due to lack of user input.
The method shown in
The CGM sensor 108 can provide sensor data to the wearable insulin delivery device 102 and/or the handheld electronic computing device 502. The handheld electronic computing device 502 can include a controller or processor and a memory. The memory can store instructions that can be executed by the controller or processor. The instructions can implemented an “artificial pancreas” algorithm. In general, the handheld electronic computing device 502 can include a controller for determining a delivery of insulin to the user (e.g., in terms of dosage amounts and times) based on data from the sensor 108 and providing a corresponding instruction regarding the determined delivery of the insulin to the wearable insulin delivery device 102.
In various embodiments, as mentioned above, the sensor 108 can be provided as part of or embedded within the wearable insulin delivery device 102. Additionally, in various embodiments, as mentioned above, the system 500 can include an intermediate wireless device (e.g., the electronic device 106 or 202) that can relay information wirelessly between the devices depicted in
In general, the system 500 can automatically monitor glucose levels of the user, automatically determine a delivery of insulin to the user based on the monitored glucose levels, and automatically provide the determined amount of insulin to the user. Each of these steps can be performed without any user input or interaction. In various embodiments, a user confirmation can be required before the insulin is provided to the user as discussed above. For example, when handheld electronic computing device 502 is implemented as a cellphone, for added security, the user can be required to confirm or acknowledge the determined delivery of insulin to the user. Without receiving such confirmation, the delivery can be blocked or prevented. This security feature can mitigate hacking or other cybersecurity risks.
As discussed above, the wearable insulin delivery device 102 can include one or more user output devices that can be used to provide an alarm, alert, or indication to the user that an instruction for insulin delivery has been determined or received. This indication can be audible, visual, and/or vibrational for example. In various embodiments, the indication can include one or more flashing light emitting diodes and/or a vibration provided by the wearable insulin delivery device 102. One or more user input devices provided with the wearable insulin delivery device 102 can be used to provide a required confirmation from the user. The input devices can include a button, a touch screen, or an accelerometer (e.g., such that the input can be a tapping or movement of the wearable insulin delivery device 102). Although user input may be needed to ensure the final step of providing the determined level of insulin to the user occurs, such embodiments can be considered as largely automatic with one or more added security features for the user.
Certain embodiments of the present invention were described above. It is, however, expressly noted that the present invention is not limited to those embodiments, but rather the intention is that additions and modifications to what was expressly described herein are also included within the scope of the invention. Moreover, it is to be understood that the features of the various embodiments described herein were not mutually exclusive and can exist in various combinations and permutations, even if such combinations or permutations were not made express herein, without departing from the spirit and scope of the invention. In fact, variations, modifications, and other implementations of what was described herein will occur to those of ordinary skill in the art without departing from the spirit and the scope of the invention. As such, the invention is not to be defined only by the preceding illustrative description. Further, many of the techniques and embodiments described are not limited to the delivery of insulin but are applicable to the automated delivery of any medication to a user.
This application is a continuation of U.S. patent application Ser. No. 15/359,187, filed Nov. 22, 2016, which claims priority to U.S. Provisional Patent Application No. 62/259,143, filed Nov. 24, 2015, and to U.S. Provisional Patent Application No. 62/290,577, filed Feb. 3, 2016, the entirety of which are hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
303013 | Horton | Aug 1884 | A |
311735 | Fenner | Feb 1885 | A |
315727 | Church | Apr 1885 | A |
405524 | Benton | Jun 1889 | A |
1177802 | Price | Apr 1916 | A |
3631847 | Hobbs | Jan 1972 | A |
3812843 | Wootten et al. | May 1974 | A |
3885662 | Schaefer | May 1975 | A |
3923426 | Theeuwes | Dec 1975 | A |
4067000 | Carlson | Jan 1978 | A |
4108177 | Pistor | Aug 1978 | A |
4151845 | Clemens | May 1979 | A |
4193397 | Tucker et al. | Mar 1980 | A |
4211998 | Junginger et al. | Jul 1980 | A |
4231019 | Junginger et al. | Oct 1980 | A |
4265241 | Portner et al. | May 1981 | A |
4268150 | Chen | May 1981 | A |
4336812 | Seragnoli | Jun 1982 | A |
4342311 | Whitney et al. | Aug 1982 | A |
4364385 | Lossef | Dec 1982 | A |
4373527 | Fischell | Feb 1983 | A |
4424720 | Bucchianer | Jan 1984 | A |
4435173 | Siposs et al. | Mar 1984 | A |
4469481 | Kobayashi | Sep 1984 | A |
4475901 | Kraegen et al. | Oct 1984 | A |
4487603 | Harris | Dec 1984 | A |
4498843 | Schneider et al. | Feb 1985 | A |
4507115 | Kambara et al. | Mar 1985 | A |
4514732 | Hayes, Jr. | Apr 1985 | A |
4529401 | Leslie et al. | Jul 1985 | A |
4551134 | Slavik et al. | Nov 1985 | A |
4559033 | Stephen et al. | Dec 1985 | A |
4559037 | Franetzki et al. | Dec 1985 | A |
4560979 | Rosskopf | Dec 1985 | A |
4562751 | Nason et al. | Jan 1986 | A |
4585439 | Michel | Apr 1986 | A |
4598719 | Mattei et al. | Jul 1986 | A |
4600020 | Mattei et al. | Jul 1986 | A |
4601707 | Albisser et al. | Jul 1986 | A |
4624661 | Arimond | Nov 1986 | A |
4634427 | Hannula et al. | Jan 1987 | A |
4678408 | Nason et al. | Jul 1987 | A |
4684368 | Kenyon | Aug 1987 | A |
4685903 | Cable et al. | Aug 1987 | A |
4734092 | Millerd | Mar 1988 | A |
4755173 | Konopka et al. | Jul 1988 | A |
4766889 | Trick et al. | Aug 1988 | A |
4781688 | Thoma et al. | Nov 1988 | A |
4781693 | Martinez et al. | Nov 1988 | A |
4791942 | Rickett et al. | Dec 1988 | A |
4801957 | Vandemoere | Jan 1989 | A |
4808161 | Kamen | Feb 1989 | A |
4836752 | Burkett | Jun 1989 | A |
4855746 | Stacy | Aug 1989 | A |
4871351 | Feingold | Oct 1989 | A |
4882600 | Van de Moere | Nov 1989 | A |
4886499 | Cirelli et al. | Dec 1989 | A |
4893640 | Heitmann et al. | Jan 1990 | A |
4898578 | Rubalcaba, Jr. | Feb 1990 | A |
4898579 | Groshong et al. | Feb 1990 | A |
4924885 | Heitmann et al. | May 1990 | A |
4944659 | Labbe et al. | Jul 1990 | A |
4969874 | Michel et al. | Nov 1990 | A |
4973998 | Gates | Nov 1990 | A |
5007458 | Marcus et al. | Apr 1991 | A |
5045871 | Reinholdson | Sep 1991 | A |
5062841 | Siegel | Nov 1991 | A |
5109850 | Blanco et al. | May 1992 | A |
5125415 | Bell | Jun 1992 | A |
5176662 | Bartholomew et al. | Jan 1993 | A |
5178609 | Ishikawa | Jan 1993 | A |
5189609 | Tivig et al. | Feb 1993 | A |
5205819 | Ross et al. | Apr 1993 | A |
5213483 | Flaherty et al. | May 1993 | A |
5232439 | Campbell et al. | Aug 1993 | A |
5239326 | Takai | Aug 1993 | A |
5242406 | Gross et al. | Sep 1993 | A |
5244463 | Cordner, Jr. et al. | Sep 1993 | A |
5245447 | Stemmle | Sep 1993 | A |
5254096 | Rondelet et al. | Oct 1993 | A |
5257980 | Van Antwerp et al. | Nov 1993 | A |
5281202 | Weber et al. | Jan 1994 | A |
5308335 | Ross et al. | May 1994 | A |
5312337 | Flaherty et al. | May 1994 | A |
5318540 | Athayde et al. | Jun 1994 | A |
5342313 | Campbell et al. | Aug 1994 | A |
5346476 | Elson | Sep 1994 | A |
5364342 | Beuchat et al. | Nov 1994 | A |
5390671 | Lord et al. | Feb 1995 | A |
5411480 | Kriesel | May 1995 | A |
5414732 | Kaufmann | May 1995 | A |
5433710 | VanAntwerp et al. | Jul 1995 | A |
5452033 | Balling et al. | Sep 1995 | A |
5492534 | Athayde et al. | Feb 1996 | A |
5505709 | Funderburk et al. | Apr 1996 | A |
5507288 | Bocker et al. | Apr 1996 | A |
5514096 | Hiejima | May 1996 | A |
5533389 | Kamen et al. | Jul 1996 | A |
5545152 | Funderburk et al. | Aug 1996 | A |
5551953 | Lattin et al. | Sep 1996 | A |
5569186 | Lord et al. | Oct 1996 | A |
5569187 | Kaiser | Oct 1996 | A |
5573342 | Patalano et al. | Nov 1996 | A |
5575770 | Melsky et al. | Nov 1996 | A |
5576781 | Deleeuw | Nov 1996 | A |
5582593 | Hultman | Dec 1996 | A |
5584813 | Livingston et al. | Dec 1996 | A |
5586553 | Halili et al. | Dec 1996 | A |
5615693 | Saitoh | Apr 1997 | A |
5630710 | Tune et al. | May 1997 | A |
5637095 | Nason et al. | Jun 1997 | A |
5643213 | McPhee | Jul 1997 | A |
5645085 | Mengoli et al. | Jul 1997 | A |
5647853 | Feldmann et al. | Jul 1997 | A |
5660728 | Saaski et al. | Aug 1997 | A |
5665065 | Colman et al. | Sep 1997 | A |
5665070 | McPhee | Sep 1997 | A |
5678539 | Schubert et al. | Oct 1997 | A |
5685844 | Marttila | Nov 1997 | A |
5685859 | Komerup | Nov 1997 | A |
5695490 | Flaherty et al. | Dec 1997 | A |
5702363 | Flaherty | Dec 1997 | A |
5704520 | Gross | Jan 1998 | A |
5726404 | Brody | Mar 1998 | A |
5726751 | Altendorf et al. | Mar 1998 | A |
5740817 | Cunningham | Apr 1998 | A |
5741228 | Lambrecht et al. | Apr 1998 | A |
5747350 | Sattler | May 1998 | A |
5748827 | Holl et al. | May 1998 | A |
5755682 | Knudson et al. | May 1998 | A |
5764159 | Neftel | Jun 1998 | A |
5776103 | Kriesel et al. | Jul 1998 | A |
5779676 | Kriesel et al. | Jul 1998 | A |
5785681 | Indravudh | Jul 1998 | A |
5785688 | Joshi et al. | Jul 1998 | A |
5797881 | Gadot | Aug 1998 | A |
5800397 | Wilson et al. | Sep 1998 | A |
5800405 | McPhee | Sep 1998 | A |
5800420 | Gross et al. | Sep 1998 | A |
5807375 | Gross et al. | Sep 1998 | A |
5810015 | Flaherty | Sep 1998 | A |
5814020 | Gross | Sep 1998 | A |
5839467 | Saaski et al. | Nov 1998 | A |
5840063 | Flaherty | Nov 1998 | A |
5840630 | Cecere et al. | Nov 1998 | A |
5845218 | Altschul | Dec 1998 | A |
5848991 | Gross et al. | Dec 1998 | A |
5851197 | Marano et al. | Dec 1998 | A |
5858005 | Kriesel | Jan 1999 | A |
5858239 | Kenley et al. | Jan 1999 | A |
5865806 | Howell | Feb 1999 | A |
5871470 | McWha | Feb 1999 | A |
5875393 | Altschul et al. | Feb 1999 | A |
5886647 | Badger et al. | Mar 1999 | A |
5891097 | Saito et al. | Apr 1999 | A |
5897530 | Jackson | Apr 1999 | A |
5906597 | McPhee | May 1999 | A |
5911716 | Rake et al. | Jun 1999 | A |
5919167 | Mulhauser et al. | Jul 1999 | A |
5931814 | Alex et al. | Aug 1999 | A |
5935099 | Peterson et al. | Aug 1999 | A |
5954058 | Flaherty | Sep 1999 | A |
5957890 | Mann et al. | Sep 1999 | A |
5957895 | Sage et al. | Sep 1999 | A |
5961492 | Kriesel et al. | Oct 1999 | A |
5965848 | Altschul et al. | Oct 1999 | A |
5983094 | Altschul et al. | Nov 1999 | A |
5983136 | Kamen | Nov 1999 | A |
5984894 | Poulsen et al. | Nov 1999 | A |
5993423 | Choi | Nov 1999 | A |
5997501 | Gross et al. | Dec 1999 | A |
6019747 | McPhee | Feb 2000 | A |
6024539 | Blomquist | Feb 2000 | A |
6050457 | Arnold et al. | Apr 2000 | A |
6061580 | Altschul et al. | May 2000 | A |
6071292 | Makower et al. | Jun 2000 | A |
6144847 | Altschul et al. | Nov 2000 | A |
6152898 | Olsen | Nov 2000 | A |
6159188 | Laibovitz et al. | Dec 2000 | A |
6171264 | Bader | Jan 2001 | B1 |
6174300 | Kriesel et al. | Jan 2001 | B1 |
6190359 | Heruth | Feb 2001 | B1 |
6206850 | ONeil | Mar 2001 | B1 |
6244776 | Wiley | Jun 2001 | B1 |
6363609 | Pickren | Apr 2002 | B1 |
6375638 | Nason et al. | Apr 2002 | B2 |
6427088 | Bowman, IV et al. | Jul 2002 | B1 |
6485462 | Kriesel | Nov 2002 | B1 |
6520936 | Mann | Feb 2003 | B1 |
6527744 | Kriesel et al. | Mar 2003 | B1 |
6554798 | Mann et al. | Apr 2003 | B1 |
6558320 | Causey, III et al. | May 2003 | B1 |
6582585 | Ruimi et al. | Jun 2003 | B2 |
6641533 | Causey, III | Nov 2003 | B2 |
6645142 | Braig et al. | Nov 2003 | B2 |
6656158 | Mahoney et al. | Dec 2003 | B2 |
6656159 | Flaherty | Dec 2003 | B2 |
6669669 | Flaherty et al. | Dec 2003 | B2 |
6689091 | Bui et al. | Feb 2004 | B2 |
6692457 | Flaherty | Feb 2004 | B2 |
6723072 | Flaherty et al. | Apr 2004 | B2 |
6740059 | Flaherty | May 2004 | B2 |
6749587 | Flaherty | Jun 2004 | B2 |
6768425 | Flaherty et al. | Jul 2004 | B2 |
6809653 | Mann et al. | Oct 2004 | B1 |
6960192 | Flaherty et al. | Nov 2005 | B1 |
7018360 | Flaherty et al. | Mar 2006 | B2 |
7029455 | Flaherty | Apr 2006 | B2 |
7083593 | Stultz | Aug 2006 | B2 |
7128727 | Flaherty et al. | Oct 2006 | B2 |
7137964 | Flaherty | Nov 2006 | B2 |
7144384 | Gorman et al. | Dec 2006 | B2 |
7875022 | Wenger | Jan 2011 | B2 |
7887505 | Flaherty | Feb 2011 | B2 |
7887511 | Mernoe et al. | Feb 2011 | B2 |
8140275 | Campbell et al. | Mar 2012 | B2 |
8622954 | Shahmirian | Jan 2014 | B2 |
8663101 | Calvosa et al. | Mar 2014 | B2 |
8721544 | Roesicke | May 2014 | B2 |
9813985 | Shapley et al. | Nov 2017 | B2 |
10046114 | Biederman et al. | Aug 2018 | B1 |
10064992 | Yang | Sep 2018 | B2 |
10448885 | Schmid | Oct 2019 | B2 |
10716896 | O'Connor | Jul 2020 | B2 |
20010056258 | Evans | Dec 2001 | A1 |
20020016568 | Lebel et al. | Feb 2002 | A1 |
20020019606 | Lebel et al. | Feb 2002 | A1 |
20020040208 | Flaherty et al. | Apr 2002 | A1 |
20020065454 | Lebel et al. | May 2002 | A1 |
20020107476 | Mann et al. | Aug 2002 | A1 |
20020123740 | Flaherty et al. | Sep 2002 | A1 |
20020126036 | Flaherty et al. | Sep 2002 | A1 |
20020169416 | Gonnelli et al. | Nov 2002 | A1 |
20030055406 | Lebel et al. | Mar 2003 | A1 |
20030065308 | Lebel et al. | Apr 2003 | A1 |
20030088238 | Poulsen | May 2003 | A1 |
20030212379 | Bylund et al. | Nov 2003 | A1 |
20030217755 | Koch et al. | Nov 2003 | A1 |
20040010207 | Flaherty et al. | Jan 2004 | A1 |
20040010507 | Bellew | Jan 2004 | A1 |
20040068224 | Couvillon, Jr. et al. | Apr 2004 | A1 |
20040092865 | Flaherty et al. | May 2004 | A1 |
20040122489 | Mazar et al. | Jun 2004 | A1 |
20040260233 | Garibotto et al. | Dec 2004 | A1 |
20050171512 | Flaherty | Aug 2005 | A1 |
20050238507 | Dilanni et al. | Oct 2005 | A1 |
20060282290 | Flaherty et al. | Dec 2006 | A1 |
20060292987 | Ophir et al. | Dec 2006 | A1 |
20070112298 | Mueller et al. | May 2007 | A1 |
20070118405 | Campbell et al. | May 2007 | A1 |
20070281617 | Meylan et al. | Dec 2007 | A1 |
20090048556 | Durand | Feb 2009 | A1 |
20090062767 | Van Antwerp et al. | Mar 2009 | A1 |
20090076359 | Peyser | Mar 2009 | A1 |
20090112769 | Dicks et al. | Apr 2009 | A1 |
20100137784 | Cefai et al. | Jun 2010 | A1 |
20110009824 | Yodfat et al. | Jan 2011 | A1 |
20110047499 | Mandro et al. | Feb 2011 | A1 |
20110071765 | Yodfat et al. | Mar 2011 | A1 |
20110093286 | Dicks et al. | Apr 2011 | A1 |
20110118578 | Timmerman | May 2011 | A1 |
20110118694 | Yodfat et al. | May 2011 | A1 |
20110124996 | Reinke et al. | May 2011 | A1 |
20110257496 | Terashima et al. | Oct 2011 | A1 |
20110316562 | Cefai et al. | Dec 2011 | A1 |
20120029941 | Malave et al. | Feb 2012 | A1 |
20120182939 | Rajan et al. | Jul 2012 | A1 |
20120266251 | Birthwhistle et al. | Oct 2012 | A1 |
20120277667 | Yodat et al. | Nov 2012 | A1 |
20140039383 | DobbLes et al. | Feb 2014 | A1 |
20140148779 | Rao et al. | May 2014 | A1 |
20140180203 | Budiman et al. | Jun 2014 | A1 |
20140309615 | Mazlish | Oct 2014 | A1 |
20150038898 | Palmer et al. | Feb 2015 | A1 |
20150057634 | Mastrototaro et al. | Feb 2015 | A1 |
20150057807 | Mastrototaro et al. | Feb 2015 | A1 |
20150119666 | Brister et al. | Apr 2015 | A1 |
20150164390 | Larvenz | Jun 2015 | A1 |
20150173674 | Hayes et al. | Jun 2015 | A1 |
20150217052 | Keenan et al. | Aug 2015 | A1 |
20150366945 | Greene | Dec 2015 | A1 |
20160183794 | Gannon et al. | Jun 2016 | A1 |
20170100536 | Estes | Apr 2017 | A1 |
20170112531 | Schoonmaker et al. | Apr 2017 | A1 |
20170117622 | Backman et al. | Apr 2017 | A1 |
20180008770 | Savoie et al. | Jan 2018 | A1 |
20180075200 | Davis et al. | Mar 2018 | A1 |
20180307515 | Meller et al. | Oct 2018 | A1 |
20190117133 | Halac et al. | Apr 2019 | A1 |
20190132801 | Kamath et al. | May 2019 | A1 |
20190150805 | Routh et al. | May 2019 | A1 |
20190321545 | Saint | Oct 2019 | A1 |
20200037939 | Castagna et al. | Feb 2020 | A1 |
20200147304 | Crouther et al. | May 2020 | A1 |
Number | Date | Country |
---|---|---|
2423717 | Apr 2002 | CA |
1476566 | Feb 2004 | CN |
4200595 | Jul 1993 | DE |
19920896 | Nov 2000 | DE |
0319272 | Jun 1989 | EP |
0342947 | Nov 1989 | EP |
0755636 | Jan 1997 | EP |
0763369 | Mar 1997 | EP |
0867196 | Sep 1998 | EP |
0937475 | Aug 1999 | EP |
1177802 | Feb 2002 | EP |
8101658 | Jun 1981 | WO |
8606796 | Nov 1986 | WO |
9800193 | Jan 1998 | WO |
9801071 | Jan 1998 | WO |
9841267 | Sep 1998 | WO |
9910040 | Mar 1999 | WO |
9910049 | Mar 1999 | WO |
9956803 | Nov 1999 | WO |
9962576 | Dec 1999 | WO |
0010628 | Mar 2000 | WO |
0013580 | Mar 2000 | WO |
0019887 | Apr 2000 | WO |
0029047 | May 2000 | WO |
0029049 | May 2000 | WO |
0030705 | Jun 2000 | WO |
0048112 | Aug 2000 | WO |
0061215 | Oct 2000 | WO |
0074752 | Dec 2000 | WO |
0078210 | Dec 2000 | WO |
0152727 | Jul 2001 | WO |
0015663 | Aug 2001 | WO |
0156633 | Aug 2001 | WO |
0176684 | Oct 2001 | WO |
0220073 | Mar 2002 | WO |
0226282 | Apr 2002 | WO |
2003090509 | Nov 2003 | WO |
2014136105 | Sep 2014 | WO |
Entry |
---|
US 5,954,699 A, 09/1999, Jost et al. (withdrawn) |
International Search Report for the International Patent Application No. PCT/US03/03731, dated Jul. 2, 2003. |
International Preliminary Examining Authority, International Preliminary Examination Report PCT/US01/27108, dated Nov. 6, 2003. |
International Preliminary Examining Authority, International Preliminary Examination Report PCT/US01/10933, dated Oct. 30, 2003. |
International Preliminary Examining Authority, International Preliminary Examination PCT/US01/31089, dated Dec. 9, 2004. |
International Preliminary Examining Authority, International Preliminary Examination Report PCT/US03/28769, dated Aug. 16, 2004. |
International Preliminary Examining Authority, International Search Report PCT/US03/28769, dated Jun. 23, 2004. |
International Preliminary Examining Authority, International Search Report PCT/US03/29019, dated Aug. 2, 2004. |
Communication Pursuant To Article 96(2) EPC EPA No. 01987579.8 (dated Jan. 26, 2005). |
International Preliminary Examining Authority, International Preliminary Examination Report PCT/US03/09952, dated Jan. 22, 2004. |
International Preliminary Examining Authority, International Preliminary Examination Report PCT/US02/05338, dated Apr. 8, 2003. |
International Preliminary Examining Authority, International Preliminary Examination Report PCT/US03/12370, dated Feb. 2, 2007. |
International Preliminary Examining Authority, International Preliminary Examination Report PCT/US03/16545, dated Mar. 22, 2004. |
International Preliminary Examining Authority, International Search Report PCT/US01/31089, dated May 16, 2002. |
International Preliminary Examining Authority, International Search Report PCT/US02/30803, dated Mar. 8, 2003. |
International Preliminary Examining Authority, International Search Report PCT/US03/09952, dated Mar. 12, 2003. |
International Preliminary Examining Authority, International Search Report PCT/US03/16545, dated Oct. 6, 2003. |
International Preliminary Examining Authority, International Search Report PCT/US03/19756, dated Mar. 10, 2004. |
International Searching Authority, International Preliminary Examination Report PCT/US03/16640, dated Mar. 15, 2004. |
International Searching Authority, International Search Report PCT/US01/51285, dated Jun. 11, 2002. |
International Searching Authority, International Search Report PCT/US03/16640, dated Oct. 2, 2003. |
International Preliminary Examining Authority, International Preliminary Examination Report PCT/US03/09606, dated Jan. 22, 2004. |
International Preliminary Examining Authority, International Preliminary Examination Report PCT/US02/28053, dated Dec. 13, 2004. |
Communication Pursuant to Article 96(2) Epc Epa No. 01977472.8 (dated Jul. 19, 2004). |
Communication Pursuant to Article 96(2) EPC EPA No. 01968320.0 (dated Jan. 21, 2005). |
International Preliminary Examining Authority, International Search Report PCT/US02/05338, dated Dec. 18, 2002. |
International Preliminary Examining Authority, International Search Report PCT/US01/27108, dated Apr. 3, 2002. |
International Search Report for the International Patent Application No. PCT/US01/10933, dated Aug. 21, 2001. |
International Search Report and Written Opinion for the International Patent Application No. PCT/US04/13804, dated Nov. 16, 2004. |
International Preliminary Examination Report for the International Patent Application No. PCT/US03/03731, dated Mar. 29, 2005. |
International Preliminary Examining Authority, International Search Report PCT/US02/28053, dated May 20, 2003. |
International Preliminary Examining Authority, International Search Report PCT/US03/09606, dated Oct. 20, 2003. |
International Search Report for the International Patent Application No. PCT/US16/63420, dated Mar. 29, 2017, 9 pages. |
International Search Report for the International Patent Application No. PCT/US01/31089, dated May 16, 2002, 3 pages. |
International Search Report for the International Patent Application No. PCT/US01/50581, dated Sep. 30, 2002, 3 pages. |
Preliminary Report on Patentability dated Dec. 21, 2017, issued in PCT International Patent Application No. PCT/US2016/037189, 12 pages. |
PCT Search Report and Written Opinion dated Sep. 9, 2016, received in corresponding PCT Application No. PCT/US16/37189, 12 pgs. |
International Search Report for the International Patent Application No. PCT/US03/12370, dated Dec. 15, 2003, 1 page. |
Web-Site Brochure dated Jan. 4, 2000. MiniMed 508. “Doing its job. Naturally.” www.minimed.com/tiles/mm_113.htm. |
Web-site Brochure dated Dec. 20, 1999. Applied Medical Technology. “508 Pump Information”. Www.applied-medical.co.uk/508.htm. |
Web-Site Brochure dated Jan. 4, 2000. “The Glucose Sensor”. Www.animascorp.com/sensor_f.html. |
Web-Site Brochure dated Dec. 20, 1999. “The Animas R-1000 Insulin Pump”. Www.animascorp.com/pump_f_s.html. |
Web-Site Brochure dated Dec. 20, 1999. “The Animas R-1000 Insulin Pump”. Www.animascorp.com/pump_f_f.html. |
Web-site Brochure dated Jan. 4, 2000. SOOIL—Homepage. “Portable Insulin Pump”. Www.sooil.com/intro2.htm. |
Web-Site Brochure dated Jan. 4, 2000. SOOIL—Homepage. “Portable Insulin Pump”. Www.sooil.com/product2.htm. |
Web-Site Brochure dated Jan. 4, 2000. SOOIL—Homepage. “Portable Insulin Pump”. Www.sooil.com/product3.htm. |
Web-Site Brochure dated Jan. 4, 2000. SOOIL—Homepage. “Portable Insulin Pump”. Www.sooil.com/product4.htm. |
User's Guide for Model 508 Insulin Pump, MiniMed, 8/00, 145 pages. |
International Search Report for the International Patent Application No. PCT/GB2015/050249, dated Jul. 7, 2015, 18 pages. |
International Search Report and Written Opinion for the International Patent Application No. PCT/US2021/064041, dated Apr. 29, 2022, 11 pages. |
International Search Report and Written Opinion for the International Patent Application No. PCT/US2022/013139, dated May 18, 2022, 12 pages. |
International Search Report and Written Opinion for the International Patent Application No. PCT/US2021/063918, dated May 30, 2022, 10 pages. |
International Search Report for International Patent Application No. PCT/US03/28769, dated Jun. 23, 2004, 1 page. |
International Search Report for International Application No. PCT/US02/28053, dated May 20, 2003, 1 page. |
International Search Report for International Application No. PCT/US03/03731, dated Jul. 2, 2003, 2 pages. |
International Search Report for International Patent Application No. PCT/US01/51285, dated Nov. 11, 2002. |
International Search Report for International Patent Application No. PCT/US03/29019, dated Aug. 2, 2004, 1 page. |
International Search Report and Written Opinion for the International Patent Application No. PCT/US21/064056, dated Apr. 1, 2022, 12 pages. |
Anonymous: “AndroidAPS ComponentOverview”, AndroidAPS documentation, Nov. 12, 2020 (Nov. 12, 2020), pp. 1-7, Retrieved from the Internet: URL:https://github.com/openaps/AndroidAPSdocs/blob/199ef86a900adf4b3d9c32f605eb11047bd3d62f/docs/EN/Module/module.rst [retrieved on Apr. 11, 2022] the whole document. |
International Search Report and Written Opinion for the International Patent Application No. PCT/US2021/063914, dated Apr. 13, 2022, 11 pages. |
Number | Date | Country | |
---|---|---|---|
20200324048 A1 | Oct 2020 | US |
Number | Date | Country | |
---|---|---|---|
62290577 | Feb 2016 | US | |
62259143 | Nov 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15359187 | Nov 2016 | US |
Child | 16898529 | US |